FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Press Releases

March 18, 2010
Quintiles Examines Asia-Pacific Drug Development Landscape in New Report
Antisoma initiates phase IIb trial of AS1411 in acute myeloid leukaemia
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) t
ARCA Announces Receipt of NASDAQ Notice per NASDAQ Rule 5810(b)
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Novelos Therapeutics, Inc. (NVLT) Discontinues Current Development Program for NOV-002 in NSCLC; Primary and Secondary Endpoints
Commercialization in close cooperation with RIEMSER Arzneimittel AG
KOHL ASKS DRUGMAKERS TO EXPLAIN INTERNATIONAL PRICE DISPARITIES
Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
Vectura & Sandoz Revise VR315 Agreement
FDA Concludes that Bavarian Nordic has Fulfilled all Requirements to Support the Delivery of IMVAMUNE to the US Government
NIH Announces Genetic Testing Registry
Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the EU to help prevent
GPhA Statement on Patent Settlements
TEVA TO ACQUIRE RATIOPHARM
Roche uniquely positioned to deliver long-term growth
March 17, 2010
Prometheus and Bayer Schering Pharma to Apply Novel Diagnostic Platform to Oncology Therapeutic Candidates
R&D Investment by U.S. Biopharmaceutical Companies
Unigene Receives Additional Capital in Debt Restructuring; Begins to Revamp Management Team
Roche Investor Day 2010
Molecular Insight Pharmaceuticals Receives NASDAQ Notification Letter
OSI Pharmaceuticals Comments on Astellas' Slate of Director Nominees
Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' Annual Stockholders Meeting
HUMAN GENOME SCIENCES ANNOUNCES RESULTS OF RANDOMIZED PHASE 2 TRIAL OF MAPATUMUMAB IN NON-SMALL CELL LUNG CANCER
Teva Provides Update on Generic Temodar
Novartis Pharma Reports Positive Results From Phase II LCZ696 Trial
Ambry Genetics, RainDance Technologies Announce Partnership for Diagnostics and Genomics Services
Cytokinetics Announces Changes to Its Board of Directors
Berndt Modig appointed as Chief Financial Officer
IMS Announces 17 Countries Now Rank as High-Growth 'Pharmerging' Markets; Forecast to Contribute Nearly Half of Industry Growth
123456789…next ›last »